Inspire Medical Systems. has been granted a patent for a system that uses an image-based navigation interface to identify stimulation locations on nerves. The system applies electrical stimulation to potential therapy sites, detects muscle responses, and visually displays activated muscles on a graphical interface for treating sleep-disordered breathing. GlobalData’s report on Inspire Medical Systems gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Inspire Medical Systems, Cardiac activity monitoring wearables was a key innovation area identified from patents. Inspire Medical Systems's grant share as of July 2024 was 42%. Grant share is based on the ratio of number of grants to total number of patents.
Nerve stimulation system for treating sleep disordered breathing
The granted patent US12053289B2 describes a sophisticated system designed to facilitate the placement of an implantable therapy stimulation element aimed at treating sleep-disordered breathing. Central to this system is a controller equipped with a processing unit and a non-transitory memory that stores executable instructions. These instructions enable the application of electrical stimulation signals at various potential therapy sites along a nerve in the head-and-neck region of a patient. The system is capable of detecting the neuromuscular responses of corresponding muscles to these stimulation signals, providing real-time visualizations of internal images of the head-and-neck area. Notably, the system can visually identify activated muscles superimposed on these images, enhancing the precision of the therapy.
Further features of the system include the ability to differentiate between stimulation applied directly to muscles versus that applied to the nerve innervating those muscles. The system can also identify target therapy stimulation sites and access pathways for delivering the implantable therapy element. The instructions encompass the generation of real-time visualizations that indicate the degree of muscle response and the specific locations of nerves and muscles involved in the treatment. The system may utilize a stimulation test tool that operates independently of the implantable therapy element, allowing for a comprehensive assessment of potential therapy sites before the actual implantation. Overall, this patent outlines a methodical approach to improving the treatment of sleep-disordered breathing through targeted neuromuscular stimulation.
To know more about GlobalData’s detailed insights on Inspire Medical Systems, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
